NovoCure Ltd - Ordinary Shares, no par value per share (NVCR)

CUSIP: G6674U108

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / Ordinary Shares, no par value per share
Shares outstanding
112,245,592
Total 13F shares
69,182,535
Share change
+1,899,411
Total reported value
$5,829,865,247
Put/Call ratio
97%
Price per share
$84.27
Number of holders
256
Value change
+$164,443,633
Number of buys
124
Number of sells
108

Quarterly Holders Quick Answers

What is CUSIP G6674U108?
CUSIP G6674U108 identifies NVCR - NovoCure Ltd - Ordinary Shares, no par value per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) as of Q4 2019

As of 31 Dec 2019, NovoCure Ltd - Ordinary Shares, no par value per share (NVCR) was held by 256 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 69,182,535 shares. The largest 10 holders included FMR LLC, BAILLIE GIFFORD & CO, VANGUARD GROUP INC, BlackRock Inc., Capital World Investors, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, Capital International Investors, MORGAN STANLEY, and Darsana Capital Partners LP. This page lists 256 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.